Experimental cell therapy trial offers hope for advanced throat cancer patients
NCT ID NCT05261750
Summary
This early-stage trial is testing whether two different immune cell therapies are safe and might help control advanced nasopharyngeal cancer. The study involves 15 patients who have already received standard treatments like radiation or chemotherapy. Researchers are comparing standard care alone against standard care plus either of two experimental immune cell treatments to see if they improve patients' daily functioning and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PT Prodia StemCell Indonesia
Jakarta, Indonesia
Conditions
Explore the condition pages connected to this study.